These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33256086)

  • 61. Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.
    Dasari VR; Kaur K; Velpula KK; Gujrati M; Fassett D; Klopfenstein JD; Dinh DH; Rao JS
    PLoS One; 2010 Apr; 5(4):e10350. PubMed ID: 20436671
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy.
    Li Y; Guessous F; DiPierro C; Zhang Y; Mudrick T; Fuller L; Johnson E; Marcinkiewicz L; Engelhardt M; Kefas B; Schiff D; Kim J; Abounader R
    Mol Cancer Ther; 2009 Feb; 8(2):376-85. PubMed ID: 19190120
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation.
    Rong X; Huang B; Qiu S; Li X; He L; Peng Y
    Oncotarget; 2016 Dec; 7(51):83976-83986. PubMed ID: 27824617
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
    Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
    Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-tumor effects of progesterone in human glioblastoma multiforme: role of PI3K/Akt/mTOR signaling.
    Atif F; Yousuf S; Stein DG
    J Steroid Biochem Mol Biol; 2015 Feb; 146():62-73. PubMed ID: 24787660
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tangeretin induces cell cycle arrest and apoptosis through upregulation of PTEN expression in glioma cells.
    Ma LL; Wang DW; Yu XD; Zhou YL
    Biomed Pharmacother; 2016 Jul; 81():491-496. PubMed ID: 27261630
    [TBL] [Abstract][Full Text] [Related]  

  • 67. VAOS, a novel vanadyl complexes of alginate saccharides, inducing apoptosis via activation of AKT-dependent ROS production in NSCLC.
    Zhou L; Yi Y; Yuan Q; Zhang J; Li Y; Wang P; Xu M; Xie S
    Free Radic Biol Med; 2018 Dec; 129():177-185. PubMed ID: 30223019
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK/AKT pathway.
    Zhu YG; Lv YX; Guo CY; Xiao ZM; Jiang QG; Kuang H; Zhang WH; Hu P
    Life Sci; 2021 Apr; 270():119112. PubMed ID: 33508300
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis.
    Zhang R; Banik NL; Ray SK
    Brain Res; 2008 Nov; 1239():216-25. PubMed ID: 18804099
    [TBL] [Abstract][Full Text] [Related]  

  • 70. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PTEN overexpression promotes glioblastoma death through triggering mitochondrial division and inactivating the Akt pathway.
    Bao L; Li X; Lin Z
    J Recept Signal Transduct Res; 2019 Jun; 39(3):215-225. PubMed ID: 31464538
    [No Abstract]   [Full Text] [Related]  

  • 72. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.
    Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G
    Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850
    [TBL] [Abstract][Full Text] [Related]  

  • 73. PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling.
    Thomas SL; Alam R; Lemke N; Schultz LR; Gutiérrez JA; Rempel SA
    Neuro Oncol; 2010 Sep; 12(9):941-55. PubMed ID: 20472716
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.
    Li J; Davies BR; Han S; Zhou M; Bai Y; Zhang J; Xu Y; Tang L; Wang H; Liu YJ; Yin X; Ji Q; Yu DH
    J Transl Med; 2013 Oct; 11():241. PubMed ID: 24088382
    [TBL] [Abstract][Full Text] [Related]  

  • 76. KML001 enhances anticancer activity of gemcitabine against pancreatic cancer cells.
    Yang MH; Lee KT; Yang S; Lee JK; Lee KH; Rhee JC
    Anticancer Res; 2015 Jan; 35(1):183-9. PubMed ID: 25550550
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antitumoral effect of arsenic compound, sodium metaarsenite (KML001), on multiple myeloma cells.
    Kim SJ; Kim ES; Kim S; Uhm J; Won YW; Park BB; Choi JH; Lee YY
    Int J Oncol; 2017 Dec; 51(6):1739-1746. PubMed ID: 29039521
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.
    Dhar S; Kumar A; Li K; Tzivion G; Levenson AS
    Biochim Biophys Acta; 2015 Feb; 1853(2):265-75. PubMed ID: 25447541
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 80. NBM-HD-3, a novel histone deacetylase inhibitor with anticancer activity through modulation of PTEN and AKT in brain cancer cells.
    Huang WJ; Lin CW; Lee CY; Chi LL; Chao YC; Wang HN; Chiou BL; Chen TJ; Huang CY; Chen CN
    J Ethnopharmacol; 2011 Jun; 136(1):156-67. PubMed ID: 21530633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.